SB-509-0401

· Sangamo Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SB-509-0401, covering 2011-06-08 to 2011-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of SB-509-0401 in Subjects With Diabetic Neuropathy [Phase 1]